December 01, 2025

Dana-Farber Research News 12.01.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from November 1 - 15.

Dana-Farber

November 24, 2025

Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated NSCLC After Tyrosine Kinase Inhibitor Failure

Sacituzumab tirumotecan, a novel TROP2 antibody-drug conjugate, was found to significantly improve both progression-free and overall survival compared with platinum-based chemotherapy in patients with...

The ASCO Post

November 19, 2025

Lung Cancer Treatment Evolutions Include Surgical Innovation and Molecular Targeted Therapy

Lung cancer survival rates have approximately doubled over the past two decades — a remarkable achievement driven by convergent advances in early detection, surgical technique and molecular oncology.

Baptist Health South Florida

November 19, 2025

Project ASCENT: Advancing Lung Cancer Screening in Hispanic Populations

Lung cancer remains the leading cause of cancer mortality in the United States, surpassing the combined deaths of breast, colon and prostate cancers.

Baptist Health South Florida

November 19, 2025

Expanding Treatment Options for Brain Metastases in NSCLC

Brain metastases in non-small cell lung cancer (NSCLC) have historically presented significant treatment challenges with limited options

Baptist Health South Florida

November 05, 2025

New Report: Lung Cancer Advancements Are Saving More Lives Than Ever, but Funding Cuts May Hinder Progress

The American Lung Association’s eighth annual “State of Lung Cancer” report highlights how the toll of lung cancer varies by state and examines key indicators throughout the United States, including n...

The ASCO Post

April 22, 2019

Management of Side Effects for Patients Receiving Multimodality Therapy in Thoracic Oncology

Lung cancer treatments come with significant challenges; managing toxicities is crucial for patient success, according to insights from experts at JADPRO Live 2018.

JADPRO

January 01, 0001

Nutrition Screening and Counseling in Patients With Lung Cancer in an Outpatient Setting

Explore how a targeted nutrition counseling intervention positively impacted malnourished lung cancer patients' health outcomes in a recent pilot study.

JADPRO

February 17, 2023

Study Finds Neoadjuvant Nivolumab Led to Improved 5-Year Survival Outcomes in Patients With Resectable NSCLC

The results from a 5-year follow-up analysis of a small clinical trial of patients with stage I to IIIA non­–small cell lung cancer (NSCLC) who were treated with nivolumab for 4 weeks before surgery s...

The ASCO Post